Idorsia announces the nomination of three candidates for election to the Board of Directors
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial…
Idorsia successfully completes an upsized offering of shares funding the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION,…
Idorsia successfully completes convertible bonds restructuring
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August…
Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August…


